Hypertension

Study: When to treat hypertension and intensify treatment

Study: When to treat hypertension and intensify treatment

Precise blood pressure level and time points at which intervening with antihypertensives was associated with a decreased risk of death.

Hypertension may increase risk for developing glaucoma

Hypertension may increase risk for developing glaucoma

Chronic hypertension may increase a person's risk for developing glaucoma.

Bevacizumab-induced hypertension is a marker for improved outcomes in recurrent glioblastoma

Bevacizumab-induced hypertension is a marker for improved outcomes in recurrent glioblastoma

Researchers have found that bevacizumab-induced hypertension may be a predictive marker of improved outcomes in patients with recurrent glioblastoma who are treated with bevacizumab.

Baseline hypertension, ASIs affect hypertension, survival during VEGF inhibitor therapy

Baseline hypertension, ASIs affect hypertension, survival during VEGF inhibitor therapy

By

Baseline hypertension and BMI can affect worsening hypertension among patients administered vascular endothelial growth factor signaling pathway inhibitors, according to research presented at the 2014 ASCO Annual Meeting.

New syndrome of hypertension related to new cancer therapies emerges

By

The mechanisms underlying VEGF-inhibitor-induced hypertension need to be better understood and clear guidelines and improved management are needed, according to a recent review.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs